AVERY CATLIN - 16 May 2024 Form 4 Insider Report for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Role
Director
Signature
/s/ Sean Moran, attorney-in-fact for Avery Catlin
Issuer symbol
CRBP
Transactions as of
16 May 2024
Net transactions value
$0
Form type
4
Filing time
20 May 2024, 16:55:28 UTC
Previous filing
22 May 2023
Next filing
03 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRBP Stock Option (right to buy) Award $0 +2,783 $0.000000 2,783 16 May 2024 Common Stock 2,783 $45.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The annual option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant.